⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iiic lung cancer

Every month we try and update this database with for stage iiic lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung CancerNCT04005144
ALK Gene Rearra...
Lung Non-Small ...
Progressive Dis...
ROS1 Gene Rearr...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Binimetinib
Brigatinib
18 Years - University of California, San Francisco
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung CancerNCT04005144
ALK Gene Rearra...
Lung Non-Small ...
Progressive Dis...
ROS1 Gene Rearr...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Binimetinib
Brigatinib
18 Years - University of California, San Francisco
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: